Location History:
- Hiromachi, JP (1993)
- Tokyo, JP (1991 - 2004)
Company Filing History:
6 out of 613 
1 out of 1 
1 out of 1 Years Active: 1991-2004
Title: Innovative Contributions of Ichiro Kawashima in the Field of Expression Systems
Introduction
Ichiro Kawashima, a prominent inventor based in Tokyo, Japan, has made significant strides in the field of biochemistry and biotechnology. With a remarkable portfolio that includes seven patents, Kawashima's contributions have been instrumental in advancing our understanding of expression systems for exogenous polypeptides. His latest inventions are paving the way for innovative treatments targeted at oxidative stress-related disorders.
Latest Patents
Kawashima's recent patents revolve around expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide. The invention details how these expression systems can be harnessed for exogenous polypeptides expressed as fusion proteins alongside the clover yellow virus Nuclear Inclusion a (NIa). This NIa component is critical as it facilitates the autolysis of the fusion protein post-expression. Notably, this system can be employed to express a new polypeptide, designated as KM31-7 protein, which exhibits the ability to reduce dichloroindophenol and reduced glutathione. These properties render the KM31-7 protein promising in the treatment of disorders rooted in oxidative stress.
Career Highlights
Throughout his career, Ichiro Kawashima has collaborated with esteemed organizations such as Sankyo Company, Limited and Kabushikigaisha Toyo Seisakusho. His roles in these companies have enabled him to refine his expertise and contribute to significant advancements in the biotechnological landscape. His work continues to influence modern research and applications.
Collaborations
In his journey, Kawashima has worked alongside several talented individuals, including Tokio Tani and Hidehiko Furukawa. These collaborations have fostered a productive environment for innovation, enabling the development of groundbreaking technologies that address pressing scientific challenges.
Conclusion
Ichiro Kawashima represents a dynamic force in the realm of inventions, particularly concerning biotechnological applications. His innovative expression systems and the development of the KM31-7 protein showcase his dedication to improving health outcomes through scientific advancement. With a solid foundation of patents and impactful collaborations, Kawashima continues to be a source of inspiration for fellow inventors and researchers in the industry.